{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:52:01Z","timestamp":1782143521451,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100012351","name":"Mitsubishi Tanabe Pharma Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012351","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Patient"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s40271-026-00807-4","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T17:10:52Z","timestamp":1772212252000},"page":"587-600","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preferences for Healthcare Delivery in Amyotrophic Lateral Sclerosis (ALS): A Survey of Patients and Caregivers in the United States"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1405-8687","authenticated-orcid":false,"given":"Ilene L.","family":"Hollin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8318-7533","authenticated-orcid":false,"given":"Hristelina","family":"Ilieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3385-2707","authenticated-orcid":false,"given":"Piera","family":"Pasinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9910-1041","authenticated-orcid":false,"given":"Terry","family":"Heiman-Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"1-2","key":"807_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1080\/21678421.2022.2059380","volume":"24","author":"P Mehta","year":"2023","unstructured":"Mehta P, Raymond J, Punjani R, et al. Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017. Amyotroph Lateral Scler Frontotemporal Degener. 2023;24(1\u20132):108\u201316. https:\/\/doi.org\/10.1080\/21678421.2022.2059380. ((In eng)).","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"4","key":"807_CR2","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1212\/01.wnl.0000172911.39167.b6","volume":"65","author":"GM Ringholz","year":"2005","unstructured":"Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65(4):586\u201390. https:\/\/doi.org\/10.1212\/01.wnl.0000172911.39167.b6. ((In eng)).","journal-title":"Neurology"},{"issue":"15","key":"807_CR3","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1212\/WNL.0b013e3181bc0141","volume":"73","author":"RG Miller","year":"2009","unstructured":"Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1218\u201326. https:\/\/doi.org\/10.1212\/WNL.0b013e3181bc0141.","journal-title":"Neurology"},{"issue":"7","key":"807_CR4","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1212\/wnl.52.7.1311","volume":"52","author":"RG Miller","year":"1999","unstructured":"Miller RG, Rosenberg JA, Gelinas DF, et al. <article-title update=\"added\">Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review) [RETIRED]: Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 1999;52(7):1311\u201323. https:\/\/doi.org\/10.1212\/wnl.52.7.1311.","journal-title":"Neurology"},{"issue":"5","key":"807_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1212\/WNL.0000000000207166","volume":"101","author":"KA Kvam","year":"2023","unstructured":"Kvam KA, Benatar M, Brownlee A, et al. Amyotrophic Lateral Sclerosis Quality Measurement Set 2022 Update: Quality Improvement in Neurology. Neurology. 2023;101(5):223\u201332. https:\/\/doi.org\/10.1212\/WNL.0000000000207166.","journal-title":"Neurology"},{"issue":"3-4","key":"807_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3109\/21678421.2013.875706","volume":"15","author":"RG Miller","year":"2014","unstructured":"Miller RG, Brooks BR, Swain-Eng RJ, et al. Quality improvement in neurology: amyotrophic lateral sclerosis quality measures. Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(3\u20134):165\u20138. https:\/\/doi.org\/10.3109\/21678421.2013.875706.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"1","key":"807_CR7","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1002\/ana.21556","volume":"65","author":"RG Miller","year":"2009","unstructured":"Miller RG, Anderson F, Brooks BR, Mitsumoto H, Bradley WG, Ringel SP. Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database. Ann Neurol. 2009;65(1):S24\u20138. https:\/\/doi.org\/10.1002\/ana.21556. ((In eng)).","journal-title":"Ann Neurol"},{"issue":"4","key":"807_CR8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/ene.12941","volume":"23","author":"B Marin","year":"2016","unstructured":"Marin B, Beghi E, Vial C, et al. Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres. Eur J Neurol. 2016;23(4):787\u201395. https:\/\/doi.org\/10.1111\/ene.12941.","journal-title":"Eur J Neurol"},{"issue":"7-8","key":"807_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/21678421.2017.1349151","volume":"18","author":"S Martin","year":"2017","unstructured":"Martin S, Trevor-Jones E, Khan S, et al. The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(7\u20138):569\u201375. https:\/\/doi.org\/10.1080\/21678421.2017.1349151. ((In eng)).","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"9","key":"807_CR10","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1136\/jnnp.74.9.1258","volume":"74","author":"BJ Traynor","year":"2003","unstructured":"Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry. 2003;74(9):1258\u201361. https:\/\/doi.org\/10.1136\/jnnp.74.9.1258. ((In eng)).","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"807_CR11","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1212\/01.wnl.0000180717.29273.12","volume":"65","author":"JP den Van Berg","year":"2005","unstructured":"den Van Berg JP, Kalmijn S, Lindeman E, et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology. 2005;65(8):1264\u20137. https:\/\/doi.org\/10.1212\/01.wnl.0000180717.29273.12. ((In eng)).","journal-title":"Neurology"},{"issue":"8","key":"807_CR12","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00415-006-0401-y","volume":"254","author":"S Zoccolella","year":"2007","unstructured":"Zoccolella S, Beghi E, Palagano G, et al. ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy. J Neurol. 2007;254(8):1107\u201312. https:\/\/doi.org\/10.1007\/s00415-006-0401-y. ((In eng)).","journal-title":"J Neurol"},{"key":"807_CR13","doi-asserted-by":"publisher","unstructured":"The EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis: Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)\u2014revised report of an EFNS task force. Euro J Neuro. 2012;19:360\u201375. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03501.x.","DOI":"10.1111\/j.1468-1331.2011.03501.x"},{"issue":"4","key":"807_CR14","doi-asserted-by":"publisher","first-page":"e210015","DOI":"10.1212\/wnl.0000000000210015","volume":"104","author":"IL Hollin","year":"2025","unstructured":"Hollin IL, Giler G, Heiman-Patterson TD. Health care delivery and financial considerations in Amyotrophic Lateral Sclerosis clinics: a survey of clinic directors. Neurology. 2025;104(4):e210015. https:\/\/doi.org\/10.1212\/wnl.0000000000210015. (In eng).","journal-title":"Neurology"},{"issue":"3-4","key":"807_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/21678421.2024.2447919","volume":"26","author":"P Mehta","year":"2025","unstructured":"Mehta P, Jaime R, Theresa N, et al. Amyotrophic lateral sclerosis estimated prevalence cases from 2022 to 2030, data from the national ALS Registry. Amyotroph Lateral Scler Frontotemporal Degener. 2025;26(3\u20134):290\u20135. https:\/\/doi.org\/10.1080\/21678421.2024.2447919.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"1","key":"807_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/0269216317709965","volume":"32","author":"J de Wit","year":"2018","unstructured":"de Wit J, Bakker LA, van Groenestijn AC, van den Berg LH, Schr\u00f6der CD, Visser-Meily JMA, et al. Caregiver burden in amyotrophic lateral sclerosis: a systematic review. Palliat Med. 2018;32(1):231\u201345. https:\/\/doi.org\/10.1177\/0269216317709965.","journal-title":"Palliat Med"},{"key":"807_CR17","unstructured":"ALS Association. ALS Focus results from the Caregiver Needs Survey, August 2021. https:\/\/www.als.org\/research\/als-focus\/survey-results\/survey-3-results. Accessed 31 Oct 2025."},{"issue":"10","key":"807_CR18","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1212\/01.WNL.0000162034.06268.37","volume":"64","author":"A Chi\u00f2","year":"2005","unstructured":"Chi\u00f2 A, Gauthier A, Calvo A, Ghiglione P, Mutani R. Caregiver burden and patients\u2019 perception of being a burden in ALS. Neurology. 2005;64(10):1780\u20132. https:\/\/doi.org\/10.1212\/01.WNL.0000162034.06268.37.","journal-title":"Neurology"},{"issue":"3\u20134","key":"807_CR19","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3109\/21678421.2014.886699","volume":"15","author":"K Qutub","year":"2014","unstructured":"Qutub K, Lacomis D, Albert SM, Feingold E. Life factors affecting depression and burden in amyotrophic lateral sclerosis caregivers. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(3\u20134):292\u20137. https:\/\/doi.org\/10.3109\/21678421.2014.886699.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"807_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jocn.2024.06.007","volume":"126","author":"L Ipek","year":"2024","unstructured":"Ipek L, G\u00fcne\u015f Gencer GY. Is caregiver burden of patients with amyotrophic lateral sclerosis related to caregivers\u2019 mindfulness, quality of life, and patients\u2019 functional level. J Clin Neurosci. 2024;126:95\u2013100. https:\/\/doi.org\/10.1016\/j.jocn.2024.06.007.","journal-title":"J Clin Neurosci"},{"issue":"2","key":"807_CR21","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1086\/259131","volume":"74","author":"K Lancaster","year":"1966","unstructured":"Lancaster K. A new approach to consumer theory. J Polit Econ. 1966;74(2):132\u201357.","journal-title":"J Polit Econ"},{"issue":"3","key":"807_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s40258-016-0232-7","volume":"14","author":"A M\u00fchlbacher","year":"2016","unstructured":"M\u00fchlbacher A, Johnson FR. Choice experiments to quantify preferences for health and healthcare: state of the practice. Appl Health Econ Health Policy. 2016;14(3):253\u201366. https:\/\/doi.org\/10.1007\/s40258-016-0232-7.","journal-title":"Appl Health Econ Health Policy"},{"issue":"3","key":"807_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1586\/erp.10.29","volume":"10","author":"TN Flynn","year":"2010","unstructured":"Flynn TN. Valuing citizen and patient preferences in health: recent developments in three types of best-worst scaling. Expert Rev Pharmacoecon Outcomes Res. 2010;10(3):259\u201367.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"807_CR24","doi-asserted-by":"crossref","unstructured":"Finn A, Louviere JJ. Determining the appropriate response to evidence of public concern: the case of food safety. J Public Policy Mark. 1992:12\u201325.","DOI":"10.1177\/074391569201100202"},{"key":"807_CR25","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s40273-016-0429-5","volume":"34","author":"KL Cheung","year":"2016","unstructured":"Cheung KL, Wijnen BF, Hollin IL, et al. Using best-worst scaling to investigate preferences in health care. Pharmacoeconomics. 2016;34:1195\u2013209. https:\/\/doi.org\/10.1007\/s40273-016-0429-5.","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"807_CR26","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s40273-022-01167-1","volume":"40","author":"IL Hollin","year":"2022","unstructured":"Hollin IL, Paskett J, Schuster ALR, Crossnohere NL, Bridges JFP. Best-worst scaling and the prioritization of objects in health: a systematic review. Pharmacoeconomics. 2022;40(9):883\u201399. https:\/\/doi.org\/10.1007\/s40273-022-01167-1. (In eng).","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"807_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/109019819502200208","volume":"22","author":"BF Campbell","year":"1995","unstructured":"Campbell BF, Sengupta S, Santos C, Lorig KR. Balanced incomplete block design: description, case study, and implications for practice. Health Educ Q. 1995;22(2):201\u201310.","journal-title":"Health Educ Q"},{"key":"807_CR28","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781107337855","volume-title":"Best-worst scaling: theory, methods and applications","author":"JJ Louviere","year":"2015","unstructured":"Louviere JJ, Flynn TN, Marley AAJ. Best-worst scaling: theory, methods and applications. Cambridge: Cambridge; 2015."},{"key":"807_CR29","doi-asserted-by":"publisher","first-page":"100394","DOI":"10.1016\/j.jocm.2022.100394","volume":"46","author":"H Aizaki","year":"2023","unstructured":"Aizaki H, Fogarty J. R packages and tutorial for case 1 best-worst scaling. J Choice Model. 2023;46:100394. https:\/\/doi.org\/10.1016\/j.jocm.2022.100394.","journal-title":"J Choice Model"},{"key":"807_CR30","unstructured":"Agency for Healthcare Research and Quality. Patient experience measures from the CAHPS Clinician & Group Survey. 2017. Document No. 2309."},{"issue":"4","key":"807_CR31","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1001\/jamaneurol.2019.4490","volume":"77","author":"CN Fournier","year":"2019","unstructured":"Fournier CN, Bedlack R, Quinn C, et al. Development and validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS). JAMA Neurol. 2019;77(4):480\u20138. https:\/\/doi.org\/10.1001\/jamaneurol.2019.4490.","journal-title":"JAMA Neurol"},{"issue":"4","key":"807_CR32","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/mus.27691","volume":"66","author":"SA Johnson","year":"2022","unstructured":"Johnson SA, Burke KM, Scheier ZA, et al. Longitudinal comparison of the self-entry Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-RSE) and Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) as outcome measures in people with amyotrophic lateral sclerosis. Muscle Nerve. 2022;66(4):495\u2013502. https:\/\/doi.org\/10.1002\/mus.27691.","journal-title":"Muscle Nerve"},{"issue":"5","key":"807_CR33","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/mus.26203","volume":"58","author":"SH Felgoise","year":"2018","unstructured":"Felgoise SH, Feinberg R, Stephens HE, et al. Amyotrophic lateral sclerosis-specific quality of life-short form (ALSSQOL-SF): a brief, reliable, and valid version of the ALSSQOL-R. Muscle Nerve. 2018;58(5):646\u201354. https:\/\/doi.org\/10.1002\/mus.26203.","journal-title":"Muscle Nerve"},{"issue":"8","key":"807_CR34","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1177\/0269216306072764","volume":"20","author":"R Cohen","year":"2006","unstructured":"Cohen R, Leis AM, Kuhl D, Charbonneau C, Ritvo P, Ashbury FD. QOLLTI-F: measuring family carer quality of life. Palliat Med. 2006;20(8):755\u201367. https:\/\/doi.org\/10.1177\/0269216306072764.","journal-title":"Palliat Med"},{"issue":"6","key":"807_CR35","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/geront\/20.6.649","volume":"20","author":"SH Zarit","year":"1980","unstructured":"Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist. 1980;20(6):649\u201355. https:\/\/doi.org\/10.1093\/geront\/20.6.649.","journal-title":"Gerontologist"},{"issue":"9","key":"807_CR36","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ\u20109: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"807_CR37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1037\/0033-295X.87.3.215","volume":"87","author":"K Ericcssson","year":"1980","unstructured":"Ericcssson K, Simon H. Verbal reports as data. Psychol Rev. 1980;87(3):215\u201351. https:\/\/doi.org\/10.1037\/0033-295X.87.3.215.","journal-title":"Psychol Rev"},{"key":"807_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-11-112","volume":"11","author":"ME Prior","year":"2011","unstructured":"Prior ME, Hamzah JC, Francis JJ, et al. Pre-validation methods for developing a patient reported outcome instrument. BMC Med Res Methodol. 2011;11:112. https:\/\/doi.org\/10.1186\/1471-2288-11-112.","journal-title":"BMC Med Res Methodol"},{"key":"807_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.12345","author":"AC M\u00fchlbacher","year":"2016","unstructured":"M\u00fchlbacher AC, Bethge S, Reed SD, Schulman KA. Patient preferences for features of healthcare delivery systems: a discrete choice experiment. Health Serv Res. 2016. https:\/\/doi.org\/10.1111\/1475-6773.12345.","journal-title":"Health Serv Res"},{"issue":"5","key":"807_CR40","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1111\/hex.12096","volume":"18","author":"S Dixon","year":"2015","unstructured":"Dixon S, Nancarrow SA, Enderby PM, Moran AM, Parker SG. Assessing patient preferences for the delivery of different community-based models of care using a discrete choice experiment. Health Expect. 2015;18(5):1204\u201314. https:\/\/doi.org\/10.1111\/hex.12096.","journal-title":"Health Expect"},{"issue":"1","key":"807_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1089\/jwh.2022.0531","volume":"33","author":"SL Graff","year":"2024","unstructured":"Graff SL, Principe J, Galvin AM, Fenton MA, Strenger R, Salama L, et al. Evaluating patient experience in a multidisciplinary breast cancer clinic: a prospective study. J Womens Health (Larchmt). 2024;33(1):39\u201344. https:\/\/doi.org\/10.1089\/jwh.2022.0531.","journal-title":"J Womens Health (Larchmt)"},{"issue":"7","key":"807_CR42","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1016\/j.cllc.2023.06.006","volume":"24","author":"H Shao","year":"2023","unstructured":"Shao H, Faris NR, Ward KD, Chen W, McHugh L, Smeltzer M, et al. Lung cancer patients\u2019 and caregivers\u2019 satisfaction with multidisciplinary versus serial care in a community healthcare setting: a prospective comparative-effectiveness cohort study. Clin Lung Cancer. 2023;24(7):e267\u201374. https:\/\/doi.org\/10.1016\/j.cllc.2023.06.006.","journal-title":"Clin Lung Cancer"},{"issue":"27","key":"807_CR43","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1056\/NEJMoa1003955","volume":"363","author":"WJ Katon","year":"2010","unstructured":"Katon WJ, Lin EH, Von Korff M, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1003955.","journal-title":"N Engl J Med"},{"issue":"1","key":"807_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/intqhc\/mzi002","volume":"17","author":"DB Preen","year":"2005","unstructured":"Preen DB, Bailey BE, Wright A, Kendall P, Phillips M, Hung J. Effects of a multidisciplinary, post-discharge continuance of care intervention on quality of life, discharge satisfaction, and hospital length of stay: a randomized controlled trial. Int J Qual Health Care. 2005;17(1):43\u201351. https:\/\/doi.org\/10.1093\/intqhc\/mzi002.","journal-title":"Int J Qual Health Care"},{"issue":"4","key":"807_CR45","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/jcpt.12536","volume":"42","author":"MYL Siaw","year":"2017","unstructured":"Siaw MYL, Ko Y, Malone DC, et al. Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (IMPACT): a randomized controlled trial. J Clin Pharm Ther. 2017;42(4):475\u201382. https:\/\/doi.org\/10.1111\/jcpt.12536.","journal-title":"J Clin Pharm Ther"}],"container-title":["The Patient - Patient-Centered Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-026-00807-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40271-026-00807-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-026-00807-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:40:32Z","timestamp":1782142832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40271-026-00807-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["807"],"URL":"https:\/\/doi.org\/10.1007\/s40271-026-00807-4","relation":{},"ISSN":["1178-1653","1178-1661"],"issn-type":[{"value":"1178-1653","type":"print"},{"value":"1178-1661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was funded by Mitsubishi Tanabe Pharma America as part of a grant titled\n                      \u201cCharacterizing outcomes, costs and preferences for treatment settings for patients with ALS and their caregivers.\n                      \u201d","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Anonymized data that supports these findings may be made available by the authors upon reasonable request from any qualified investigator.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Terry Heiman-Patterson and Ilene Hollin conceptualized the overall study. All authors contributed to the design of the instruments and contributed equally to the acquisition of data. Ilene Hollin conducted the data analysis and drafted the original draft manuscript. All authors commented on previous versions of the manuscript and all authors read and approved the final manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"Ilene Hollin is a member of the editorial board of The Patient. She was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. She received salary support from Mitsubishi Tanabe Pharma America for this study. She receives research support that is unrelated from the NIH (K01HL161330). Hristelina Ilieva is a site-PI for the Healey trial, receives research support from Mitsubishi Tanabe Pharma America, Sanofi, and Farber Family Foundation. Piera Pasinelli is supported by grants from NIH (RO1 NS136624; R21 AG093032); ALSUM; Aldrich Foundation; Family Strong4ALS, and Farber Family Foundation. L. Chisholm is supported by funding from Mitsubishi Tanabe Pharma for this grant and has no other relevant disclosures. T. Heiman-Patterson is supported by Mitsubishi Tanabe Pharma America. She receives unrelated funding as site PI for clinical trials from COYA therapeutics, Amylyx, Arcellx, and the Healey Platform trial. She is site PI for All ALS and for the Natural History Consortium.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institution Review Board of Temple University (protocol #29392). The IRB determined that written consent was not required as responding to the survey implied participant consent.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}